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Chitosan,which is a non-toxic, biodegradable andbiocompatible biopolymer, has beenwidely researched
for several applications in the ﬁeld of biomaterials. Calcium phosphate ceramics stand out among the
so-called bioceramics for their absence of local or systemic toxicity, their non-response to foreign bodies
or inﬂammations, and their apparent ability to bond to the host tissue. Hydroxyapatite (HA) is one of
the most important bioceramics because it is the main component of the mineral phase of bone. The
aim of this work was to produce chitosan membranes coated with hydroxyapatite using the modiﬁed
biomimetic method. Membranes were synthesized from a solution containing 2% of chitosan in aceticiomimetic method
hitosan
embranes and hydroxyapatite
acid (weight/volume) via the solvent evaporationmethod. Specimenswere immersed in a sodiumsilicate
solution and then in a 1.5 SBF (simulated body ﬂuid) solution. The crystallinity of the HA formed over the
membranes was correlated to the use of the nucleation agent (the sodium silicate solution itself). Coated
membranes were characterized by means of scanning electron microscopy – SEM, X-ray diffraction –
XRD, and Fourier transform infrared spectroscopy – FTIR. The results indicate a homogeneous coating
covering the entire surface of the membrane and the production of a semi-crystalline hydroxyapatite
al phlayer similar to the miner
. Introduction
Interest in the use of chitosan for medical and pharmaceutical
pplications has been growing, especially because of its remarkable
roperties such as biocompatibility, which makes it suitable for
everal medical applications [1,2].
The wide variety of shapes that chitosan can be delivered in,
.g., ﬁlms, membranes, ﬁbers, gel, paste, tablets, microspheres, as
ell as ﬂakes, powders and solutions, enables it to be employed
n several commercial, industrial, environmental and biomedical
pplications [3]. Until a few years ago, chitosan was used mainly
o remove sediments and metallic ions from water, as well as in
he food industry. Currently, chitosan is used in the production of
osmetics, medicines, food additives, and semi-permeable mem-
ranes, and in the development of biomaterials for medical and
ental applications.
The development and use of several kinds of biomaterials in for
issue reconstruction procedures are growing. Calcium phosphate
eramics are used especially for this purpose due to their biocom-
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patibility and osteocompatibility and their structural, physical and
chemical similarity to the bone mineral matrix [4].
The use of these bioceramics does not induce any undesirable
immunological or toxic reaction. There is no risk of transmission
of infectious or contagious pathologies or of protein degradation
because of their characteristics and their high purity, which is a
result of the rigid control of the manufacturing process according
to the strictest standards [5].
Hydroxyapatite is noteworthy because it is themain constituent
of the mineral phase of calciﬁed tissues. HA is a ceramic calcium
phosphate, or bioceramic, whose structure and composition are
similar to the mineral phase of bones and teeth [6]. Synthetic HA is
also biocompatible and osteointegrable, which makes it one of the
most important substitutes for the human bone in implants and
prostheses. In technological applications, HA is used as a coating
for metallic implants and periodontal membranes [7].
Relatively recent studies consider the use of chitosan as a bio-
material because of its compatibility with live organisms and also
Open access under the Elsevier OA license.due to economic reasons, since it derives from chitin, which is very
abundant in nature. In view of the increasing use of chitosan as a
biomaterial, the production of an organic mineral containing chi-
tosan and hydroxyapatite should be studied, particularly due to
the possible interactions between these constituents. The aim of
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Table 1
Ionic concentrations of the solutions used to coat apatites (mM) [9].
Na+ K+ Ca2+ Mg2+ HCO32− Cl− HPO42− SO42− SiO32−
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aBlood plasma 142.0 5.0 2.5 1.5
SBF 142.0 5.0 2.5 1.5
1.5 SBF 213.0 7.5 3.8 2.3
Na2SiO3 2.0 – – –
he present work is to study and produce chitosan membranes
oated with hydroxyapatite by the modiﬁed biomimetic method
or possible application as a biomaterial.
. Materials and methods
All the reagents used here were of analytical grade. Commercial
hitosan (Sigma) was extracted from crab, and contained at least
5% of deacetylated chitin.
.1. Production of chitosan membranes
Chitosan membranes were produced from a solution contain-
ng 2% of chitosan in acetic acid (weight/volume). This solution was
tored for one week at 4 ◦C to allow for its complete solubilization
ccording to the method proposed by Beppu et al. [8]. The solution
as vacuum ﬁltered to eliminate air bubbles and to prevent the
ormation of macro-defects on the surface of the membranes after
ynthesizing. The membranes were prepared by pouring the chi-
osan solution into 2 cm×3 cm TeﬂonTM molds with a controlled
hickness of 3mm. The molds containing the solution were then
ried for 72h at 40 ◦C, after which the membranes were immersed
n 1mol/L NaOH solution for 24h at 25 ◦C.
.2. Coating of chitosan membranes with hydroxyapatite
In this work, we chose to use a modiﬁed version of the
iomimetic method introduced by Abe et al. [5]. Rigo et al. [9]
ubstituted the treatment with G glass from the original method
roposed by Abe and coworkers by immersion in a sodium silicate
SS) solution, which acts as a nucleation agent. [9,10]
The membranes were coated with and without treatment in SS,
sing the following routes: S1 – membranes were immersed in 1.5
BF solution for 3 days at 37 ◦C and pH=7.0; S2 – membranes were
mmersed in the SS solution for 3 days at 37 ◦C and then in 1.5
BF for 3 days at 37 ◦C and pH=7.0, according to the procedure
escribed by Rigo et al. [9]; S3 – membranes were immersed in the
S solution for 3 days at 37 ◦C and then in 1.5 SBF for 7 days at 37 ◦C
nd pH=7.0. Table 1 lists the ionic concentrations of blood plasma
nd all the solutions used in this process [10].
.3. Scanning electron microscopy
A morphological analysis of the membranes was performed by
canning electron microscopy (SEM), using a Philips TMP micro-
cope. Organic specimens were coated with gold to improve their
lectrical conductivity.
.4. X-ray diffractionThepresence of crystalline phases in the coatedmembraneswas
nalyzedbyX-raydiffraction (XRD), using a SiemensD5005diffrac-
ometer with Cu (k1) radiation and angular scanning between 4◦
nd 70◦.27.0 103.0 1.0 0.5 –
4.2 148.0 1.0 0.5 –
6.3 223.0 1.5 0.75 –
– – – – 3.6
2.5. Fourier transform infrared spectroscopy
The ionic groups were characterized by vibrational infrared
spectroscopy, using a Nicolet Magna 550 FTIR spectrophotometer
with DRIFT CollectorTM diffuse reﬂectance.
3. Results and discussion
The kinetic of formation of apatites via the biomimetic process
using SBF solution follows the sequence shown in Eq. (1) [11].
(ACP) Ca10−xH2x(PO4)6(OH)2 → (OCP) Ca8H2(PO4)6 · 5H2O
→ (HA)Ca10(PO4)6(OH)2 (1)
According to several authors, in the initial steps of apatite
precipitation, low calcium content hydroxyapatite can become
hydroxyapatite without transforming into octacalcium phosphate
(OCP). Processing parameters such as pH (neutral or alkaline), tem-
perature and solution concentration are very important for the
crystallization of calcium phosphates until the HA phase is formed.
Phenomena such as precipitation, solubilization, and slow and
effective dehydration at a molecular level lead to the formation of
a molecular arrangement that allows for the phase transformation
of apatites [4].
Fig. 1 depicts the coatings produced in all the conditions
employed in this study. The coating produced without the nucle-
ation agent SS (condition S1) shows a dense homogeneous layer on
the surface with an undeﬁned morphology of ACP, which is one of
the precursors of HA. The morphology of the HA coating pretreated
with sodium silicate (condition S2) is dense and uniform, consist-
ing of spherical particles of 1–5m, similar to those reported in the
literature for HA coatings on metals [12,13]. The coating produced
in condition S3 was dense. However, after 7 days of exposure to
the 1.5 SBF solution, the coating showed surface cracks and some
of its outer spherical particles were not bonded to inner particles.
This indicates that the concentration at the surface of the coating
became saturated when compared to the concentration of the 1.5
SBF solution [4]. After 4 days of exposure to the 1.5 SBF solution, the
reaction at equilibrium changed from precipitation to dissolution
of the HA layer.
Fig. 2 shows the proposed coating mechanism of CS membranes
with HA by means of the biomimetic method. Carbon in position 6
– C6 in CS has a free hydroxyl group that can help activation of the
membrane surface by silanol groups of the SS solution. The silicate
ions in the SS solution are adsorbed on the CS substrate (Fig. 2a);
HA nucleation of the adsorbed silicate ions begins (Fig. 2b); HA
nucleons grow because of the saturated 1.5 SBF solution, leading to
the coating of the substrate (Fig. 2c).
Hydroxyapatite Ca10(PO4)6(OH)2 has vibrational modes of
phosphates and hydroxyls [14]. Table 2 shows the absorption fre-
quencies for calcium phosphates.
The spectrum in Fig. 3 showsHA absorption bands at 3570 cm−1and at about 630 cm−1. The band at 3570 cm−1 is related to OH−
stretching, which is attributed to the HA functional group. How-
ever, this region shows broadening of the band, which increases
with exposure time to the 1.5 SBF solution due to the water in the
structure, a common occurrence in non-heat-treated coatings.
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Fig. 1. SEM characterization of chitosan/HA coated membranes. (S1) Membrane with no addition of SS and 3 days in 1.5 SBF; (S2) 3 days in SS and 3 days in 1.5 SBF; (S3) 3
days in SS and 3 days in 1.5 SBF.
Fig. 2. Proposed coating mechanism of CS membranes with HA by means of biomimetic method. (a) The membrane is submitted to a treatment with sodium silicate solution;
(b) membrane immersed in 1.5 SBF solution; (c) HA formation onto the surface.
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Table 2
Characteristic calcium phosphates infrared absorption.
Absorption band Wavenumber (cm−1)
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The bands at 2880 cm−1 (C–H stretching), 1660 cm−1 (C–C
tretching) and 1390 cm−1 (C–O stretching) are attributed to the
S structure.
The band at 2330 cm−1 is attributed to the presence of CO2 in
he measuring chamber of the device in which the specimen was
laced, and is part of the equipment’s background noise.
The bands at 1170 cm−1 and 1130 cm−1 are attributed to P–O
tretching, while the bands close to 600 cm−1 are related to P–O
eformation vibrations of the PO43− group [15].
The bands between 850 and 1000 cm−1 are attributed to P–OH
tretching.AcharacteristicbandofHA isvisibleat around630 cm−1,
hich represents the OH end-group with lower steric impediment
f the structure [15].
The XRD measurements were taken using the PDF #39-194,
DF #18-0303, and PDF #373-1731 standards for CS, ACP and HA,
espectively [16]. A region of low crystallinity was visible between
5◦ and 25◦, corresponding to a diffraction halo of the CS mem-
rane.
The fact that the specimens showed low crystallinity is inter-
sting since, according to Kanazawa [4], human bone consists of a
ixture of calcium phosphates of low crystallinity. Discrete peaks
ig. 4. XRD patterns for chitosan/HA membranes. (S1) Membrane with no addition of SS a
ays in 1.5 SBF; (S2/bone) human bone and S2 condition.Fig. 3. FTIR spectra of chitosan/HA membranes. (S1) Membrane with no addition of
SS and 3 days in 1.5 SBF; (S2) 3 days in SS and 3 days in 1.5 SBF; (S3) 3 days in SS
and 3 days in 1.5 SBF.
of the ACP phase (S1) close to 30◦ and 35◦ are shown in Fig. 4. The
membrane pretreated in SS solution (S2) and exposed to the 1.5
SBF solution for 3 days shows peaks of low crystallinity related to
the HA phase which are very similar to the ones Vercik [17] iden-
tiﬁed in metallic substrates. This is a carbonated hydroxyapatite
very similar to the biological one, which is characterized by its low
crystallinity.
nd 3 days in 1.5 SBF; (S2) 3 days in SS and 3 days in 1.5 SBF; (S3) 3 days in SS and 3
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A tendency forhigher crystallizationwasobserved in theS3 con-
ition. This behavior was expected because of the longer exposure
o the 1.5 SBF solution (7 days). During that time, solubilization and
eprecipitation of HA occurred, as indicated by the SEM analysis.
his led to the slow formation of nuclei and the subsequent growth
f more oriented crystals, favoring the formation of HA phase.
Fig. 4 compares the biological HA of human bone and the results
btained for the coating of S2 specimen. Back in 1926, De Jong [18]
as the ﬁrst to observe the similarity between X-ray spectra of
he mineral phase of bone and HA. However, the mineral phase
f bone does not have a deﬁnite composition because it varies
uring the maturing and aging stages of hard tissues. Thus, the
ain difference between synthetic HA and bone apatite lies in their
rystallinity [19]. The similarity between diffractograms of human
one and the one found experimentally (S2 condition) is shown in
ig. 4.
. Conclusions
The modiﬁed biomimetic method proposed here enabled us to
orkwith thekineticsof the solution reactions, allowing for control
f the degree of crystallinity of the HA layer.
The use of sodium silicate as a nucleation agent in the produc-
ion of hydroxyapatite coating affected the phase formation of the
patites. After immersing the membranes in sodium silicate solu-
ion, it was found that distinct calcium phosphate phases were
ormed by varying the exposure time to 1.5 SBF solution.
The longer the exposure time to the 1.5 SBF solution the more
rystalline the coating and the lower its adhesion to the substrate.
[
[
[
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The conditions employed in this study led to the formation of a
low crystallinity hydroxyapatite layer similar to human bone.
Acknowledgments
The authors would like to thank CNPq and FAPESP (Brazil) for
their ﬁnancial support of this work.
References
[1] J. Berger, M. Reist, J.M. Mayer, O. Felt, N.A. Peppas, R. Gurny, Eur. J. Pharm.
Biopharm. 57 (2004) 19.
[2] M.R. Finisie, A. Josue, V.T. Favere, M.C.M. Laranjeira, Anais da Academia
Brasileira de Ciências 73 (2001) 525.
[3] M.N.V.R. Kumar, React. Funct. Polym. 46 (2000) 1.
[4] T. Kanazawa, Inorganic Phosphate materials, Elsevier, Tokyo, 1989, pp. 15–17.
[5] Y. Abe, T. Kokubo, T. Yamamuro, J. Mater. Sci.: Mater. Med. 1 (1990) 536.
[6] R.Z. Legeros, H.M. Myers, Monogr. Oral Sci. 15 (1991) 15.
[7] E.Y. Kawachi, Quim. Nova 23 (2000) 518.
[8] M.M. Beppu, E.J. Arruda, C.C. Santanam, Pol.: Ciên. e Tecn. (1999) 163.
[9] E.C.S. Rigo, A.O. Boschi, M. Yoshimoto, Mater. Sci. Eng. C 24 (2004) 647.
10] J. Pierri, E.B. Roslindo, R. Tomasi, J. Non-Cryst. Solids 352 (2006) 5279.
11] H.Aoki, ScienceandMedicalApplicationsofHydroxyapatite, JAAS, Tokyo, 1991,
p. 230.
12] H.M. Kim, F. Miyaji, T. Kokubo, C. Ohtsuki, T. Nakamura, J. Am. Ceram. Soc. 78
(1995) 2405.
13] T. Kokubo, Acta Mater. 46 (1998) 2519.
14] H. Zeng, W.R. Lacefeld, Biomaterials 21 (2000) 23.
15] J.C. Elliot, Structure and Chemistry of the Apatites and Other CalciumOrthophosphates, Elsevier, New York, 1984, p. 389.
16] Joint Committee for Powder Diffraction Studies – Diffraction Data Base. Inter-
national for Diffraction Data, Newton Square, 2003. 1 CD-ROM.
17] L.C.O. Vercik, Doctoral Thesis, UNESP, 2004, p. 127.
18] W.F. De Jong, Recl. Trav. Chim. 45 (1926) 445.
19] A.F. Fraga, Master’s Dissertation, UFSCar, 2007, p. 120.
